Drospirenone (DRSP) Birth Control Pills:  YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Vestura / Beyaz / Safyral

What are YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral?

YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral are the only birth control pills, or oral contraceptives, to contain the progestin drospirenone (DRSP).

YAZ, Yasmin, Beyaz, and Safyral are manufactured by Bayer HealthCare Pharmaceuticals, Inc. Yasmin was originally made by Berlex Laboratories, which was acquired by Bayer in 2006.

Ocella is a generic version of Yasmin.  Gianvi is a generic version of YAZ.  The Ocella and Gianvi birth control pills are from Teva Pharmaceuticals and Barr Laboratories.

Zarah is a generic version of Yasmin.  Vestura is a generic version of YAZ.  The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals.

Loryna, a generic version of YAZ, and Syeda, a generic version of Yasmin, are made and sold by Sandoz, Inc.

Each of these birth control pills contain ethinyl estradiol (EE) and the progestin drospirenone (DRSP). These DRSP oral contraceptives have also been associated with several different adverse side effects such as:

• Blood Clots
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Stroke
• Cerebrovascular Accidents (CVA)
• Heart Attack
• Myocardial Infarction
• Gallbladder Disease / Injury (cholecystitis)
• Gallbladder Removal (cholecystectomy)
• Death

January 2012 Update: The January 9, 2012 Sims v. Bayer "bellwether", or test, trial has been postponed indefintely, and Judge David Herndon has ordered mediation for the entire Yasmin and YAZ MDL litigation in order to see if some or all of these federal court lawsuits can be settled.

See: CASE MANAGEMENT ORDER NUMBER 53 -- Regarding Bellwether Plan

Yaz Birth Control Investigation

Nightline from ABC News (video)

(10/14/2011)

YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Vestura / Beyaz / Safyral: Serious Side-Effects Lawsuit News And Information Hub

This is an up-to-date collection of drug injury lawyer blog posts and selected news articles regarding legal claims involving YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Vestura / Beyaz / Safyral birth control pills.

Bayer May Have Misled Women About Health Risks Of Their Popular Yasmin And YAZ Birth Control Pills

As of November 2011 over 10,000 lawsuits filed concerning YAZ / Yasmin side effects such as pulmonary embolism (PE), deep vein thrombosis (DVT), and gallbladder removal, with more cases being investigated by our law firm and other lawyers.

The YAZ Label Change In March 2011 Seems Rather "Generic" In Nature

There is nothing specific about YAZ in the new warning language added to the YAZ label in March 2011; rather, these new warnings about blood clots and pancreatitis seem to pertain to ALL combined oral contraceptives (COCs), or birth control pills.

YAZ / Yasmin / Ocella MDL Update October 2010: Bellwether, or Early Trial, Cases Set To Begin In September 2011 Per Judge Herndon Order

More than 3700 lawsuits filed to date: 41% are venous thromboembolisms (VTE), including pulmonary embolisms (PE) and deep vein thrombosis (DVT); 43% are gallbladder injuries; 10% are strokes and heart attacks / myocardial infarctions (MI).

More Than 2600 Yaz / Yasmin / Ocella Lawsuits Have Been Filed As Of August 2010

This August 2010 MDL lawsuit number does not include the Yaz / Yasmin / Ocella personal injury and wrongful death lawsuits that have been filed in the New Jersey state court "mass tort" consolidation (426 cases as of August 12, 2010) nor the Yaz / Yasmin / Ocella cases that have been filed in the Pennsylvania state court system.

March 2010: YAZ / Yasmin / Ocella Litigation Update: More Than 1,100 Lawsuits Filed To Date

These drospirenone (DRSP) containing contraceptives are associated with several serious side effects like blood clots, stroke, and heart attack, as well as lesser known side effects such as gallbladder disease and pancreatitis.  With the number of lawsuits growing, most injury and death cases are being filed in the federal MDL.

Ocella, Yasmin, YAZ, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, And Safyral Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack

Some medical journal articles are linking certain oral contraceptives such as Ocella, Yasmin, Safyral, Zarah, and Syeda as well as YAZ, Beyaz, Gianvi, Loryna, and Vestura to pulmonary embolism (PE) and deep vein thrombosis (DVT). These birth control pills each contain drospirenone (DRSP), a unique progestin which causes an increased risk of thromboembolism, or blood clot, side effects when compared to older oral contraceptives (OCs). Estrogen and DRSP create a potentially life-threatening combination due to their coagulative effects.

Yasmin And YAZ MDL (Multidistrict Litigation) Assigned To Judge David R. Herndon, Southern District of Illinois

On October 1, 2009 the United States Judicial Panel on Multidistrict Litigation (JPML) issued a Transfer Order which creates MDL No. 2100. This means that all YAZ and Yasmin personal injury and wrongful death cases filed in the federal court system will be consolidated into a Multidistrict Litigation, or MDL, with U.S. District Court Judge David R. Herndon presiding over these YAZ and Yasmin cases.

In 2009 Bayer Was Required To Correct Advertising Information About Benefits And Risks Of Its YAZ Birth Control Pill

In 2009 Bayer was required to run a $20 million advertising campaign to correct previous YAZ advertisements that overstated the benefits and understated the risks of this popular birth control pill after getting an FDA warning letter. Back in 2003, the FDA sent a similar warning letter about misleading ads for Yasmin.

How And Why YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, And Safyral Pills Might Cause A Higher Rate Of Blood Clots In Women

All hormonal birth control options are associated with some health risks. However, the oral contraceptive pills YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral have the distinction of being associated with a possible higher rate of blood clots which can cause serious side effects – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis. The obvious questions are “How?” and “Why?”.

Are The Current Warnings About Blood Clot Side Effects Associated With YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, And Safyral Sufficient?

Although the package inserts for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral carry a bolded warning for the increased risk of hyperkalemia associated with these birth control pills, any warnings for the associated blood clot risks are found in only regular print. Now lawsuits are being filed on behalf of women who used these birth control pills alleging there has been a failure to warn about the increased risk of blood clots.

Birth Control Pill YAZ Being Reviewed For Increased Risk Of Blood Clots And Serious Side Effects

YAZ is an oral contraceptive, or birth control pill, which combines the new "fourth generation" progestin drospirenone (DRSP) and ethinyl estradiol. YAZ has been associated with several dangerous side effects such as deep vein thrombosis (DVT), pulmonary embolism (PE), heart attacks, and strokes.

Blood Clot Side Effects Have Long Been A Safety Issue For Yasmin As Well As Its Generic Versions, Ocella, Zarah, And Syeda

Soon after the Yasmin birth control pill was approved in 2000 there were reports of pulmonary embolism (PE) and deep vein thrombosis (DVT). As a result in 2002 general practitioners in The Netherlands were warned against prescribing Yasmin over the well-known second generation birth control pills.

Oral Contraceptives Such As YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, And Safyral Found To Increase The Risk For Gallbladder Disease

Increasingly, medical studies are finding a clear and formidable link between hormonal contraceptive pills like YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral, and gallbladder complications. These gallbladder injuries, such as acute cholecystitis, often end in gallbladder removal surgery, or cholecystectomy.

Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery

For women who are using estrogen-progestin methods of birth control -- such as YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral -- here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.

YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral Class Actions

We believe that people who suffered a serious injury or death due to the YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, or Safyral oral contraceptive pills are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, or Safyral class actions together with the claims of many other people who may have had different injuries caused by these birth control pills.

Legal Compensation for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, and Safyral Injuries

If you experienced serious side effects from the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, or Safyral, or a person died due to an adverse reaction while taking these birth control pills containing drospirenone (DRSP), you may have a claim for legal compensation. Such claims involving a serious injury or death caused by the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Vestura, Beyaz, or Safyral are made by filing a lawsuit in court. All states have statutes of limitations that determine the deadlines by which to file lawsuits involving these drospirenone (DRSP) oral contraceptives.

Free Case Evaluation:  YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Vestura / Beyaz / Safyral

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

Drug Injury Watch: YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Vestura / Beyaz / Safyral News And Commentary

YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)

YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online

Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting

Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella

YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack

Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance Company

YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism

YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects

Yasmin / YAZ MDL: First Trial Moved From September 2011 To January 2012 Per Plaintiffs' Request

Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots

Another Rather "Odd" YAZ Label Change By Bayer: March 2011

YAZ / Yasmin / Ocella Litigation: February 2011 Update

YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011

August 2010 Status Update For The Yaz / Yasmin / Ocella Federal Court MDL Litigation

Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S

March 2010: Bayer Says It Will Update Yasmin Label In Europe To Add Results From Four Medical Studies

YAZ, Yasmin, Ocella: 1,100 Lawsuits Filed As Of Mid-February 2010, According To Bayer

Medical Journal Report: Adverse Drug Reactions And Pulmonary Embolism Are Often Difficult For Doctors To Diagnose

November 2009 Medical Journal Article Describes Large Ongoing Study About Safety Of YAZ

Yasmin And Yaz Birth Control Pills Are Under Scrutiny By Drug Regulators In Europe

Waiting For The Results From Swissmedic Safety Analysis Of Yaz And Other Drospirenone-Containing Contraceptives

October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court

Some Of The Drospirenone (DRSP) Progestin Used In Yaz And Yasmin Pills May Have Been Of Bad Quality

YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills

A Theory Of How Yasmin Or YAZ Might Cause Pulmonary Embolism (PE) And Other Blood Clot Related Side Effects

WebMD List Of Symptoms For Serious Side Effects From Using Estrogen-Progestin Birth Control Methods

Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed In Late July 2009

Have Yasmin-Related Blood Clot Side Effect Cases Flown Below Radar In US?

Birth Control Pill YAZ Is Subject Of Ongoing Safety Study Regarding Cardiovascular Side Effects